ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2688

Comparison of Systemic Lupus Erythematosus and Healthy Anti-Nuclear Antibody Positive African-Americans Reveals Distinct Differences in T Cell and Progenitor Populations

Rufei Lu1,2, Samantha Slight-Webb1, Holden T. Maecker3, Paul J. Utz4, Joel M. Guthridge1 and Judith A. James5,6, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Medicine and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 4Medicine, Stanford University School of Medicine, Stanford, CA, 5Clinical Arthritis and Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Rheumatology, University of Oklahoma Health Sciences Center, Oklahoma City, OK

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: African-Americans, ANA, Lupus and T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis: T and B Cell Signaling and Genetic Variants

Session Type: Abstract Submissions (ACR)

Background/Purpose Systemic lupus erythematosus (SLE) is a systemic autoimmune disorder which arises from both genetic and environmental factors that likely affect phenotypic and functional characteristics of multiple cell lineages. Further, almost all SLE individuals are antinuclear antibody positive (ANA+) although ANA positivity does not obligate autoimmune disease. The differences in cellular physiology between ANA+ healthy individuals and individuals that go on to develop SLE remains a critical goal in the understanding of SLE development. A comprehensive view of immune cell phenotypes in disease is often challenging to ascertain due to limits of assay parameters and proper visualization tools to display cellular hierarchy for high-dimensional data sets. Using mass cytometry, we visualize the expression of 33 cell surface markers through hierarchical clustering using spanning-tree progression analysis of density-normalized events (SPADE) to provide a comprehensive view of the immune system between ANA- and ANA+ healthy controls and ANA+ patients with SLE.

Methods Blood specimens and information on disease activity were collected from eight African American SLE patients. Patients were matched by age (±5 years), race, and gender to healthy individuals positive for ANA without classifiable lupus (ANA+, n=8) and ANA negative healthy controls (ANA-, n=8). Single-cell analysis of cell surface markers was completed by mass cytometry and cellular heterogeneity was analyzed using SPADE. Significant differences in cell population frequencies were determined using ANOVA and Wilcoxon rank test. Plasma samples isolated from patients at time of draw were analyzed for 51 cytokines using a multiplex immunoassay.

Results Compared to both ANA+ and ANA- healthy controls, SLE patients had lower frequencies of cytotoxic CD8+ T cells, regulatory CD4+ T cells and early progenitor cell populations (P<0.05). Significant differences in progenitor cells nodes were found in CD4 and CD8 negative CD3+ T cells and surface marker null progenitor cells. Concentrations of serum sCD40 ligand were significantly lower in patients with SLE compared with ANA+ and ANA- healthy controls (p<0.05). Interestingly, sCD40L production positively correlated with a decrease in regulatory CD4+ T cell populations (p<0.01). Further, IL-7 levels were lower in both ANA+ controls and SLE patients compared with ANA- healthy individuals (p<0.05).

Conclusion Our results indicate that early differences in progenitor cell populations may contribute to decreased levels of regulatory CD8+ and CD4+ T cells important for controlling systemic inflammation. Further, the decreased production of IL-7, which is important for the differentiation of hematopoietic stem cells into lymphoid progenitors, in SLE patients and ANA+ patients may contribute to early immune defects in progenitor lymphoid populations leading to loss of tolerance in autoimmunity.


Disclosure:

R. Lu,
None;

S. Slight-Webb,
None;

H. T. Maecker,
None;

P. J. Utz,
None;

J. M. Guthridge,
None;

J. A. James,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-systemic-lupus-erythematosus-and-healthy-anti-nuclear-antibody-positive-african-americans-reveals-distinct-differences-in-t-cell-and-progenitor-populations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology